desoxycorticosterone acetate has been researched along with Cerebral Microangiopathies in 2 studies
Desoxycorticosterone Acetate: The 21-acetate derivative of desoxycorticosterone.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guy, R | 2 |
| Volkman, R | 1 |
| Wilczynski, E | 1 |
| Yagil, C | 2 |
| Yagil, Y | 2 |
| Findler, M | 1 |
| Auriel, E | 1 |
| Nevo, U | 1 |
| Offen, D | 2 |
| Herman, S | 1 |
| Benyamini, H | 1 |
| Ben-Zur, T | 1 |
| Kobo, H | 1 |
| Pasmanik-Chor, M | 1 |
| Yaacobi, D | 1 |
| Barel, E | 1 |
2 other studies available for desoxycorticosterone acetate and Cerebral Microangiopathies
| Article | Year |
|---|---|
A Novel Rodent Model of Hypertensive Cerebral Small Vessel Disease with White Matter Hyperintensities and Peripheral Oxidative Stress.
Topics: Animals; Cerebral Hemorrhage; Cerebral Small Vessel Diseases; Desoxycorticosterone Acetate; Hyperten | 2022 |
Mesenchymal Stem Cell-Derived Extracellular Vesicles as Proposed Therapy in a Rat Model of Cerebral Small Vessel Disease.
Topics: Animals; Anti-Inflammatory Agents; Cerebral Small Vessel Diseases; Desoxycorticosterone Acetate; Dis | 2022 |